Adrenal insufficiency: identification and management

You can now review and comment on this draft guideline.

The consultation closes on 19 April 2024 at 5pm

How to comment

1. Register your organisation or comment as an individual

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

Documents to comment on:

• Draft guideline
• Evidence review A - Information and Support
• Evidence review B - When to suspect Adrenal Insufficiency
• Evidence review C - When to Refer For Steroid Withdrawal
• Evidence review D - Diagnostic Tests and Thresholds for Referral
• Evidence review E - Methods for Corticosteroid Withdrawal
• Evidence review F - Routine Pharma PrimaryAI
• Evidence review G - Routine Pharma SecondaryAI TertiaryAI
• Evidence review H - When to Suspect Adrenal Crisis
• Evidence review I - Emergency Management Adrenal Crisis
• Evidence review J - Pharma Management Physiological Stress
• Evidence review K - Pharma Management Psychological Stress
• Evidence review L - NonPharma Management Physiological Stress
• Evidence review M - NonPharma Management Psychological Stress
• Evidence review N - Ongoing care Monitoring including end of life care
• Supporting documentation - Methods chapter
• Supporting documentation - Rationale for drug doses
• Equality impact assessment - section 3

Other information about the consultation

• Committee membership list
• Developing NICE guidelines: how to get involved
• Final scope – for information

3. Add your comments

• You must use this comments form
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us

Email: hypoadrenalism@nice.org.uk

Deadline: 19/04/2024 at 5pm